Copyright
©The Author(s) 2022.
World J Clin Cases. Sep 26, 2022; 10(27): 9921-9928
Published online Sep 26, 2022. doi: 10.12998/wjcc.v10.i27.9921
Published online Sep 26, 2022. doi: 10.12998/wjcc.v10.i27.9921
Parameter | Result | Normal range |
Liver and kidney function | ||
Alanine aminotransferase | 1442.8 | 7-40 U/L |
Aspartate aminotransferase | 1565 | 13-35 U/L |
Alkaline Phosphatase | 217 | 50-135 U/L |
γ-glutamyl transferase | 183.2 | 7-45 U/L |
Total bilirubin | 110 | 3.4-22 μmol/L |
Direct bilirubin | 91.1 | 1.7-10.3 μmol/L |
Albumin | 36.9 | 40-55 g/L |
Globulin | 22.3 | 20-40 g/L |
Serum creatinine | 43.6 | 35-80 μmol/L |
Serum urea | 4.74 | 2.9-8.2 mmol/L |
Serum lipids | ||
Total cholesterol | 3.67 | 3.4-5.8 mmol/L |
Low-density lipoprotein cholesterol | 0.6 | 0.78-2 mmol/L |
High-density lipoprotein cholesterol | 1.91 | 0-3.7 mmol/L |
Triglycerides | 1.88 | 0.56-1.7 mmol/L |
Coagulation function | ||
Prothrombin Time | 13.7 | 11.0-15.0 sec |
Prothrombin activity | 86.56 | 75%-160% |
International normalized ratio | 1.02 | 0.8-1.5 |
Complete blood count | ||
Leukocyte | 1.17 | 4.5-10 × 109 cells/L |
Neutrophils | 0.02 | 1.8-6.3 × 109 cells/L |
Eosinophils | 0 | 0.02-0.52 × 109 cells/L |
Basophils | 0 | 0-0.06 × 109 cells/L |
Lymphocytes | 0.98 | 1.1-3.2 × 109 cells/L |
Monocytes | 0.17 | 0.1-0.6 × 109 cells/L |
Erythrocyte | 4.07 | 3.8-5.1 × 1012 cells/L |
Platelet | 159 | 125-350 × 109 cells/L |
Inflammatory markers | ||
C-reactive protein | 10.28 | 0-5 mg/L |
Procalcitonin | 0.192 | 0-0.05 ng/mL |
Screening for causes of acute liver injury | ||
Autoimmune liver diseases | ||
Immunoglobulin A | 1.4 | 0.72-4.29 g/L |
Immunoglobulin G | 13.3 | 8-17 g/L |
Immunoglobulin G4 | 0.427 | 0.05-1.54 g/L |
Immunoglobulin M | 1.2 | 0.29-3.44 g/L |
Anti-nuclear antibody | Negative | |
Anti-smooth muscle antibody | Negative | |
Anti-liver kidney microsome-1 | Negative | |
Anti-soluble liver antigen/liver pancreas antigen | Negative | |
Anti-liver cytosol-1 | Negative | |
Anti-centromere antibody | Negative | |
Anti-Mitochondrial-M2 antibody | Negative | |
Anti-gp210 antibodies | Negative | |
Anti-Sp100 antibodies | Negative | |
Virology test | ||
Hepatitis A IgM | Negative | |
Hepatitis B surface antigen | Negative | |
Hepatitis B core antibody IgM | Negative | |
Hepatitis C antibody | Negative | |
Hepatitis E IgM | Negative | |
Anti-CMV IgM | Negative | |
Anti-EBV viral capsid antigen IgM | Negative | |
Anti-EBV early antigen IgM | Negative | |
COVID-19 RNA | Negative | |
HBV DNA | < 100 | < 100 IU/mL |
Thyroid function | ||
Thyroid-stimulating hormone | 0.8 | 0.56-5.91 uIU/mL |
Free triiodothyronine | 4.4 | 3.53-7.37 pmol/L |
Free Thyroxine | 14.68 | 7.98-16.02 pmol/L |
Other | ||
Ceruloplasmin | 0.36 | 0.16-0.45 g/L |
Alpha-fetoprotein | 2.9 | 0.0-9.0 ng/mL |
Cell type | % | Reference value range |
Myeloblasts | 1.5 | 0.31-0.97 |
Promyelocytes | 1.5 | 1.51-1.63 |
Neutrophilic myelocytes | 2.5 | 4.45-8.53 |
Neutrophilic metamyelocytes | 2 | 5.93-9.87 |
Neutrophilic stab granulocytes | 0 | 20.22-27.22 |
Neutrophilic segmented granulocytes | 0 | 6.52-12.36 |
Eosinophils | 0 | 0.15-0.61 |
Basophils | 0 | 0.00-0.07 |
Pronormoblasts | 0.5 | 0.27-0.87 |
Early erythroblasts | 0.5 | 0.51-1.33 |
Polychromatic normoblasts | 12.5 | 5.5-9.32 |
Orthochromatic normoblasts | 33.5 | 8.39-13.11 |
Lymphocytes | 42.5 | 15.71-29.82 |
Monocytes | 2.5 | 2.12-3.88 |
Plasmacytes | 0.5 | 0.29-1.13 |
Total | 100 | |
Myeloid:erythroid ratio | 0.16 | 2-4:1 |
- Citation: Shao YL, Ma CM, Wu JM, Guo FC, Zhang SC. Concurrent severe hepatotoxicity and agranulocytosis induced by Polygonum multiflorum: A case report. World J Clin Cases 2022; 10(27): 9921-9928
- URL: https://www.wjgnet.com/2307-8960/full/v10/i27/9921.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i27.9921